A Trial Comparing Mini-posterior Approach and Direct Anterior Approach
NCT ID: NCT01024309
Last Updated: 2014-10-30
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
66 participants
INTERVENTIONAL
2009-11-30
2013-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Randomized Study of Approaches in Total Hip Arthroplasty
NCT01613508
A Randomised Trial Comparing Anterior Versus Posterior Approach in Total Hip Replacement
NCT01106560
Total Hip Arthroplasty (THA) Surgical Techniques Comparing the Direct Anterior Approach to the Posterior Approach
NCT01807104
Comparative Study of Minimally Invasive Surgical Approaches for Total Hip Arthroplasty
NCT04311125
Anterior Capsulectomy vs. Repair in Direct Anterior THA
NCT01621932
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Standard primary total hip arthroplasty (THA) can reliably alleviate pain, improve function, and improve the quality of life in a broad section of patients with end stage arthrosis of the hip. However, minimally invasive approaches, such as the direct anterior and mini-posterior approaches, have been devised with the goal of decreasing peri-operative pain, speed early postoperative function, and improve patient satisfaction with the procedure, compared with standard THA. These patient centered goals are combined with the surgeon's desire of a safe, reproducible minimally invasive procedure that has durable, properly positioned components.
There are currently no prospective, randomized studies comparing the direct anterior approach to total hip arthroplasty with other minimally invasive approaches. The mini-posterior approach has been studied extensively, with promising results. Others have compared the mini-posterior approach with other minimally invasive procedures, and at the current time, has the most prospective data demonstrating its superiority as a minimally invasive approach. Pagnano performed a prospective, randomized trial comparing the early clinical results of mini -posterior THA with Two-incision THA. The results found that the early attainment of functional milestones was shorter in the mini-posterior group.
The purpose is to determine if differences exist in the attainment of functional milestones that reflect activities of daily living between mini-posterior and direct anterior approach total hip arthroplasty (THA). The investigators also hope to determine if the general health outcome after direct anterior total hip arthroplasty was better than that after mini-posterior-incision total hip arthroplasty as measured with Short Form-12 (SF-12) scores, and to evaluate variation of surgical factors of the two procedures on the basis of the operative time, component positioning, and occurrence of early complications.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mini-Posterior Approach
Mini-Posterior surgical approach for total hip arthroplasty
Mini-Posterior surgical approach for total hip arthroplasty
Mini-Posterior surgical approach for total hip arthroplasty
Direct Anterior Approach
Direct Anterior surgical approach for total hip arthroplasty
Direct Anterior surgical approach for total hip arthroplasty
Direct Anterior surgical approach for total hip arthroplasty
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mini-Posterior surgical approach for total hip arthroplasty
Mini-Posterior surgical approach for total hip arthroplasty
Direct Anterior surgical approach for total hip arthroplasty
Direct Anterior surgical approach for total hip arthroplasty
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The subject is between 25 and 80 years of age at the time of surgery.
* The subject has elected to undergo primary total hip arthroplasty for osteoarthritis.
* The subject is psychosocially, mentally and physically able to comply with the requirements of the study including post-operative clinical, radiographic evaluations and completion of patient questionnaires.
* The subject is skeletally mature.
Exclusion Criteria
* The subject has had a previous total hip arthroplasty.
* The subject has inflammatory arthritis.
* The subject has any type of infection.
* The subject has developmental dysplasia of the hip.
* The subject has a known metal allergy.
* The subject has an extreme offset of greater than 50 mm.
* The subject has an acetabular deformity requiring advanced reconstructive techniques.
* The subject has Charcot's disease.
* The subject has Paget's disease
* Dependence on narcotics for 6 months (or longer)
25 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
OrthoCarolina Research Institute, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John Bohannon Mason, MD
Role: PRINCIPAL_INVESTIGATOR
OrthoCarolina, P.A.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OrthoCarolina, P.A.
Charlotte, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09072
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.